Lineage Cell Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2012
Total Assets: $29.7M
Liabilities Breakdown FY2012
Total Liabilities: $20.2M
Asset Breakdown
Total Assets: $29.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $4.4M | 14.6% |
| Accounts Receivable | $395.0K | 1.3% |
| Inventory | $55.3K | 0.2% |
| Property, Plant & Equipment | $1.3M | 4.5% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $20.5M | 68.9% |
| Other Assets | $3.1M | 10.5% |
Liabilities Breakdown
Total Liabilities: $20.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.2M | 5.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $19.0M | 94.2% |